Cresanto Global Ltd. Stock price: Live updates

₹0

0% (0)

Market Cap

₹2 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

2.00 Cr

Prom Holding

32.27 %

ROE (%)

6.97

ROCE (%)

30.24

Div Yield (%)

Sales

0.05 Cr

OPM (%)

-540 %

Debt to Equity

-0.92

Institutions

0.96 %

Individual < 2 lac

30.82 %

No. of Shareholders

1,481

Edit Ratio's

About

Raymed Labs Ltd is a pharmaceutical company that specializes in manufacturing a wide range of … Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

5 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

6 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Unable to calculate due to limited data
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
Debt

Company might have issues servicing its debt
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
ROE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data
Share price

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Cresanto Global Ltd. Business

What does Cresanto Global do?

Raymed Labs Ltd specializes in the manufacturing of a diverse range of pharmaceutical products including antibiotics, anti-inflammatories, and other medications for both human and veterinary use.

Who are the competitors of Cresanto Global?

Cresanto Global major competitors are MPS Pharmaa, Fabino Enterprises, Zyden Gentec, Ganga Pharma, Hemo Organic, Decipher Labs, Hind Bio Sciences.
Market Cap of Cresanto Global is ₹2 Crs.
While the median market cap of its peers are ₹7 Crs.

Is Cresanto Global financially stable compared to its competitors?

Cresanto Global seems to be less financially stable compared to its competitors.
Altman Z score of Cresanto Global is -1142.71 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Cresanto Global Ltd.

Cresanto Global Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

5 Yes

1 Neutral

5 No

6 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Retail Holding

Promoter Holding

Other Income

Revenue Recognition

Contingent Liabilities

Price & Performance

Capex vs ROCE

Working Capital

Debt

Margin Stability

ROCE Strength

Balance Sheet Strength

ROE

Current vs Historic Valuation

Share price

Sales Growth

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Cresanto Global Ltd. Business

What does Cresanto Global do?

Who are the competitors of Cresanto Global?

Is Cresanto Global financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE